Status:
COMPLETED
Opioid Free Management After Ureteroscopy
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Kidney Stone
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this research study is to compare how well two medications work to control post-operative pain.
Detailed Description
This will be a randomized double blinded control trial with subjects randomized to either opioid group (Norco 5-325 milligram) or a non-opioid group (Ibuprofen 400 milligram). Subjects with a renal st...
Eligibility Criteria
Inclusion
- Ureteroscopy performed for renal stones
- Age over 18 years
- Two kidneys
Exclusion
- Solitary Kidney
- Poor kidney function (GFR\<30)
- Allergy to either Ibuprofen or Norco
- Pelvic Kidney
Key Trial Info
Start Date :
September 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 26 2020
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT03872843
Start Date
September 19 2019
End Date
February 26 2020
Last Update
March 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157